ÇAKIROĞLU, E. Et Al. 2024. Genome-Wide CRISPR Screens: Unveiling BUB1 Kinase as a Druggable Vulnerability in Malignant Pleural Mesothelioma. The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) , (Rotterdam, Netherlands), 183-184.

ÇAKIROĞLU, E., ERİŞ, S., Öz, Ö., KARAKÜLAH, G., & ŞENTÜRK, Ş., (2024). Genome-Wide CRISPR Screens: Unveiling BUB1 Kinase as a Druggable Vulnerability in Malignant Pleural Mesothelioma . The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) (pp.183-184). Rotterdam, Netherlands

ÇAKIROĞLU, ECE Et Al. "Genome-Wide CRISPR Screens: Unveiling BUB1 Kinase as a Druggable Vulnerability in Malignant Pleural Mesothelioma," The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), Rotterdam, Netherlands, 2024

ÇAKIROĞLU, ECE Et Al. "Genome-Wide CRISPR Screens: Unveiling BUB1 Kinase as a Druggable Vulnerability in Malignant Pleural Mesothelioma." The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) , Rotterdam, Netherlands, pp.183-184, 2024

ÇAKIROĞLU, E. Et Al. (2024) . "Genome-Wide CRISPR Screens: Unveiling BUB1 Kinase as a Druggable Vulnerability in Malignant Pleural Mesothelioma." The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) , Rotterdam, Netherlands, pp.183-184.

@conferencepaper{conferencepaper, author={ECE ÇAKIROĞLU Et Al. }, title={Genome-Wide CRISPR Screens: Unveiling BUB1 Kinase as a Druggable Vulnerability in Malignant Pleural Mesothelioma}, congress name={The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024)}, city={Rotterdam}, country={Netherlands}, year={2024}, pages={183-184} }